Roivant Sciences Ltd ROIV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
11.41quote price arrow down-0.09 (-0.78%)
Volume
3,002,261
52 week range
8.24 - 13.24
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.41
  • 52 Week High13.24
  • 52 Week High Date09/28/23
  • 52 Week Low8.24
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap9.195B
  • Shares Out805.85M
  • 10 Day Average Volume3.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change1.6

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.41
  • 52 Week High13.24
  • 52 Week High Date09/28/23
  • 52 Week Low8.24
  • 52 Week Low Date10/27/23
  • Market Cap9.195B
  • Shares Out805.85M
  • 10 Day Average Volume3.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change1.6

RATIOS/PROFITABILITY

  • EPS (TTM)5.07
  • P/E (TTM)2.25
  • Fwd P/E (NTM)-7.02
  • EBITDA (TTM)-1.052B
  • ROE (TTM)123.54%
  • Revenue (TTM)123.241M
  • Gross Margin (TTM)87.57%
  • Net Margin (TTM)3,439.02%
  • Debt To Equity (MRQ)7.37%

EVENTS

  • Earnings Date06/28/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Roivant Sciences Ltd

Profile

MORE
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline is focused on inflammation and immunology and includes VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; batoclimab and IMVT-1402, fully human monoclonal antibodies targeting the neonatal Fc...
Ilan Oren
Independent Chairman of the Board
Matthew Gline
Chief Executive Officer, Director
Eric Venker M.D.
President, Chief Operating Officer
Mayukh Sukhatme M.D.
President, Chief Investment Officer
Richard Pulik
Chief Financial Officer
Rakhi Kumar CPA
Chief Accounting Officer
Address
11-12 St. James's Square
Suite 1, 3rd Floor
London
SW1Y4LB
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
VKTX
Viking Therapeutics Inc
69.06-8.95-11.47%
CERE
Cerevel Therapeutics Holdings Inc
42.35+0.04+0.09%
ASND
Ascendis Pharma A/S
122.80-1.24-1.00%
PCVX
Vaxcyte Inc
75.45+3.82+5.33%
CYTK
Cytokinetics Inc
59.92-0.58-0.96%